GlassScriptPhysician profile
Rima Patel
NPI 1124556659
$1,501.38
in general payments reported to CMS, 2019-2025
9 companies · $404 in 2025
The $404 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2021: $493 · 2022: $204 · 2023: $159 · 2024: $99.46 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $425.19 | 2021-2025 | Datroway |
| Seagen INC. | $374.93 | 2021 | |
| Daiichi Sankyo INC. | $209.09 | 2024-2025 | Enhertu |
| Abbvie INC. | $173.23 | 2019-2023 | |
| Genzyme Corporation | $144.00 | 2023 | |
| Stemline Therapeutics INC. | $112.66 | 2025 | Orserdu |
| Novartis Pharmaceuticals Corporation | $46.63 | 2024 | |
| Allergan, INC. | $15.65 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rima Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.